Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of ...

As we reflect on 2024, I am proud to share the remarkable progress Atossa Therapeutics has made in advancing our mission to address significant unmet needs in breast cancer prevention and treatment.

In this clinical trial, 4742 postmenopausal women in 37 countries who had received initial treatment for unilateral estrogen-receptor-positive breast cancer and had been taking adjuvant tamoxifen ...

Background: Tamoxifen (Tam) is used for the treatment and prevention of estrogen-receptor-positive human breast and other cancers. Its use in ovarian cancer has not been well studied. Method ...

Tyler J. Hall pleaded guilty to introducing unapproved drugs into interstate commerce, a violation of federal law that requires FDA approval to sell the chemicals for human consumption.

Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.

A Montana fitness-based business owner faces jail time for illegally selling bodybuilding drugs that fight "man boobs." He pleaded guilty to selling ...

UC researchers reveal that miR-205 regulates MED1 and HER3, proteins driving breast cancer treatment resistance. Boosting miR-205 levels could block MED1 production and activity, enhancing therapy ...

A Tennessee man accused of creating and selling unapproved drugs for use in bodybuilding from his Kalispell business has ...

The study states that while most people believe that successful cancer treatments denote that the disease has been eradicated from the body, in estrogen receptor-positive breast cancer ...

These included models such as C57BL/6J, BALB/cJ, and B10.A mice, as well as specific transgenic strains like leptin receptor-cre recombinase (Lepr-cre), nerve/glial antigen 2-cre estrogen receptor ...